This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jiang, W. Articles by Thompson, H. J. Search for Related Content PubMed PubMed Citation Articles by Jiang, W. Articles by Thompson, H. J.

Mechanisms of Energy Restriction

Effects of Corticosterone on Cell Growth, Cell Cycle Machinery, and Apoptosis¹

Centers for Nutrition in the Prevention of Disease [W. J., Z. Z., H. J. T.] and Cancer Causation and Prevention [N. B.], AMC Cancer Research Center, Denver, Colorado 80214, and School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262 [R. A.]

The restriction of energy intake has documented beneficial effects on numerous diseases including cancer, yet the mechanism(s) that accounts for these effects is unknown. Recently, we showed that the inhibitory activity against mammary carcinogenesis mediated by energy restriction (ER) is accompanied by an increase in the secretion of adrenal cortical steroids. However, ER caused a concomitant reduction in circulating levels of insulin-like growth factor-1, which also may be involved in inhibiting carcinogenesis. To determine what cellular and molecular effects may be because of corticosterone per se, detailed mechanistic studies were performed in vitro using a mouse mammary hyperplastic cell line (TM10). The following questions were addressed: (a) is corticosterone-mediated growth inhibition accounted for by disruption of cell cycle machinery; (b) is growth inhibition accompanied by the induction of apoptosis; and (c) is growth inhibition reversible? At doses of corticosterone (50–200 µM for 24–72 h) that resulted in inhibition (up to 76%; P < 0.001) of growth, a dose- and time-dependent G₁ arrest in cell cycle progression was observed. In the studies analyzing cell cycle regulatory molecules, corticosterone treatment of cells resulted in a strong induction (up to 10-fold over control; P < 0.01) of KIP1/P27 together with a decrease (up to 98%; P < 0.01) in cyclin-dependent kinase 4 (CDK4) and cyclin D1 protein levels. Cells treated with corticosterone also showed an increased binding (up to 2.6-fold over control; P < 0.01) of KIP1/P27 with CDK4, together with a strong decrease (up to 89%; P < 0.01) in the kinase activity of the CDK4-cyclin D1 complex. Treatment of cells with KIP1/P27 antisense oligonucleotides reversed the growth inhibitory effects of corticosterone. Treatment of cells with RU 486, a glucocorticoid receptor blocker, reversed the effects of corticosterone on cell growth and KIP/P27 protein levels suggesting the involvement of the glucocorticoid receptor in accounting for these effects. Additional studies assessing the biological fate of cells after corticosterone treatment showed that corticosterone exerted reversible growth inhibitory effects with limited apoptotic cell death. Together, these findings show a reversible cytostatic effect of corticosterone via perturbations in cell cycle regulators causing a G₁ arrest in the absence of increased levels of apoptosis. These data provide evidence for a role of corticosterone on some but not all of the cellular activities associated with ER-mediated inhibition of mammary carcinogenesis.

This article has been cited by other articles:

				T. Moore, L. Beltran, S. Carbajal, S. Strom, J. Traag, S. D. Hursting, and J. DiGiovanni Dietary Energy Balance Modulates Signaling through the Akt/Mammalian Target of Rapamycin Pathways in Multiple Epithelial Tissues Cancer Prevention Research, June 1, 2008; 1(1): 65 - 76. [Abstract] [Full Text] [PDF]

				Z. Zhu, W. Jiang, J. N. McGinley, and H. J. Thompson 2-Deoxyglucose as an Energy Restriction Mimetic Agent: Effects on Mammary Carcinogenesis and on Mammary Tumor Cell Growth In vitro Cancer Res., August 1, 2005; 65(15): 7023 - 7030. [Abstract] [Full Text] [PDF]

				J. M. Wang, P. B. Johnston, B. G. Ball, and R. D. Brinton The Neurosteroid Allopregnanolone Promotes Proliferation of Rodent and Human Neural Progenitor Cells and Regulates Cell-Cycle Gene and Protein Expression J. Neurosci., May 11, 2005; 25(19): 4706 - 4718. [Abstract] [Full Text] [PDF]

				W. Jiang, Z. Zhu, J. N. McGinley, and H. J. Thompson Adrenalectomy Does Not Block the Inhibition of Mammary Carcinogenesis by Dietary Energy Restriction in Rats J. Nutr., May 1, 2004; 134(5): 1152 - 1156. [Abstract] [Full Text] [PDF]

				J. C. L. Leo, C. Guo, C. T. Woon, S. E. Aw, and V. C. L. Lin Glucocorticoid and Mineralocorticoid Cross-Talk with Progesterone Receptor to Induce Focal Adhesion and Growth Inhibition in Breast Cancer Cells Endocrinology, March 1, 2004; 145(3): 1314 - 1321. [Abstract] [Full Text] [PDF]

				Y. Wang, Z. Zhang, E. Kastens, R. A. Lubet, and M. You Mice with Alterations in Both p53 and Ink4a/Arf Display a Striking Increase in Lung Tumor Multiplicity and Progression: Differential Chemopreventive Effect of Budesonide in Wild-type and Mutant A/J Mice Cancer Res., August 1, 2003; 63(15): 4389 - 4395. [Abstract] [Full Text] [PDF]

				Z. Zhu, W. Jiang, and H. J. Thompson Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas Carcinogenesis, July 1, 2003; 24(7): 1225 - 1231. [Abstract] [Full Text] [PDF]

				W. Jiang, Z. Zhu, and H. J. Thompson Effect of Energy Restriction on Cell Cycle Machinery in 1-Methyl-1-Nitrosourea-induced Mammary Carcinomas in Rats Cancer Res., March 15, 2003; 63(6): 1228 - 1234. [Abstract] [Full Text] [PDF]